|
|||||
|
|
A company using artificial intelligence algorithms and big data analytics to discover drug targets from RNA splicing errors is the winner of a competition among start-up enterprises for innovative uses of A.I. technology. . . . → Read More: Digital Drug Discovery Company Wins A.I. Competition  2 comments - (Comments are closed)  Finance  biomedical, engineering, equity, genomics, investment, life sciences, mathematics, medical device, physical sciences, software 
A start-up company developing an app-based monitor with artificial intelligence for tracking cognitive change in older adults is taking part in a study testing the program with a chain of rehabilitation clinics. . . . → Read More: Grant Funds A.I. Cognitive Change Rehab Study 2 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, clinical trials, engineering, entrepreneurs, grant, Israel, mathematics, medical device, physical sciences, software The realm of investing offers plenty of exciting opportunities for investors of all backgrounds. Here are five of the most pertinent aspects to consider. . . . → Read More: Intelligent Investments For Inexperienced Individuals: 5 Questions You Need To Ask 
Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology. . . . → Read More: Platform to Integrate Robotics, Synthetic Biology, A.I. Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, contract, DoD, engineering, genomics, life sciences, mathematics, physical sciences, robotics 
The health care provider Kaiser Permanente plans to spend $2 million on research into preventing injuries and death from firearms, as well as begin an internal task force on firearm injury prevention. . . . → Read More: Kaiser Permanente to Spend $2M on Gun Injury Research A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal Comments are closed Finance biomedical, biotechnology, clinical trials, equity, Europe, FDA, genomics, investment, life sciences, merger, pharmaceuticals Current and former Purdue University engineering students transformed their interest in rocketry into a new enterprise for launching small lower-cost satellites into low-earth orbit from high-altitude balloons. . . . → Read More: Students Form Microsatellite Rocket Launch Company Comments are closed Finance, New products engineering, entrepreneurs, equity, investment, NASA, NSF, physical sciences, physics, space, university A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A research project is underway that examines the ways teams of workers adapt and perform in new industrial environments demanding attention to visual information as well as cues from sound and touch. . . . → Read More: Team Performance Explored in Multi-Sensory Work Sites Comments are closed Finance behavioral science, engineering, grant, manufacturing, mathematics, NSF, physical sciences, software, university An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up One comment - (Comments are closed) Finance, New products biomarkers, biomedical, cancer, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, U.K., university, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
